Accelerate Diagnostics, Inc. Provides Revenue Guidance for Fourth Quarter and Full Year 2021
For the Full Year 2021, the company expects total revenue to be $11.8 million, compared to $11.2 million a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.33 USD | -1.48% | +5.56% | -66.07% |
1st Jan change | Capi. | |
---|---|---|
-66.07% | 31.88M | |
+6.69% | 218B | |
+10.04% | 189B | |
+27.25% | 151B | |
+32.06% | 113B | |
-0.15% | 64.02B | |
+13.57% | 52.6B | |
+1.85% | 49.85B | |
-5.85% | 37.89B | |
+0.04% | 34.92B |